Miguel Segura

29PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical molecular engineering of nucleic acids and proteinsNeurology and neuromuscular diseasesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 25, 2026
Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma.

|Aug 25, 2025
Epigenetic synthetic lethality as a cancer therapeutic strategy: synergy of experimental and computational approaches.

Maria Farina-Morillas, Laia Ollé-Monràs, Silvana Ce Maas

|Sep 11, 2024
Advances in the approaches used to repurpose drugs for neuroblastoma.

Marta Miera-Maluenda, María Pérez-Torres, Adriana Mañas

|May 29, 2024
In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma.

Catherine Murphy, Laura Devis-Jauregui, Ronja Struck

|Mar 29, 2023
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon.

Guillem Pons, Gabriel Gallo-Oller, Natalia Navarro

|Feb 25, 2023
Epigenetic therapies for neuroblastoma: immunogenicity awakens.

Carlos Jiménez, Lucas Moreno, Miguel F Segura

Pageof 5

Frequent Collaborators

8 joint publications

Soledad Gallego

8 joint publications

Aroa Soriano Fernandez

7 joint publications

Josep Roma

7 joint publications

Lucas Moreno